Chris Beattie

AquaBounty, a land-based salmon producer innovating to enhance productivity and sustainability in aquaculture, has announced that Dr Chris Beattie will lead the research and development, compliance and regulatory functions of the company as Chief Scientific Officer in July 2022. Dr Beattie will retain his position as an active director of ViAqua Therapeutics, which he has held since 2021.More than 30 years' experience that combines a strong scientific understanding (PhD, fish physiology) with extensive commercial experience at AKVA Group, Merck, and Skretting North America. Based in Vancouver, Canada, Chris leads AKVA Group's North American and Australasian aquaculture technology business.